<code id='B65C95295F'></code><style id='B65C95295F'></style>
    • <acronym id='B65C95295F'></acronym>
      <center id='B65C95295F'><center id='B65C95295F'><tfoot id='B65C95295F'></tfoot></center><abbr id='B65C95295F'><dir id='B65C95295F'><tfoot id='B65C95295F'></tfoot><noframes id='B65C95295F'>

    • <optgroup id='B65C95295F'><strike id='B65C95295F'><sup id='B65C95295F'></sup></strike><code id='B65C95295F'></code></optgroup>
        1. <b id='B65C95295F'><label id='B65C95295F'><select id='B65C95295F'><dt id='B65C95295F'><span id='B65C95295F'></span></dt></select></label></b><u id='B65C95295F'></u>
          <i id='B65C95295F'><strike id='B65C95295F'><tt id='B65C95295F'><pre id='B65C95295F'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:5

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          What does generative AI mean for health care? We asked experts
          What does generative AI mean for health care? We asked experts

          MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

          read more
          Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal
          Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Results on Novartis prostate cancer therapy could expand its use

          TheNovartisboothatESMO2023inMadrid.AndrewJoseph/STATMADRID—ResultspresentedMondaycouldexpandtheuseof